Medinal (BioDeep_00000899443)

   


代谢物信息卡片


Medinal

化学式: C8H11N2O3- (183.077)
中文名称:
谱图信息: 最多检出来源 () 0%

分子结构信息

SMILES: CCC1(C(=O)NC(=O)N=C1[O-])CC
InChI: InChI=1S/C8H12N2O3/c1-3-8(4-2)5(11)9-7(13)10-6(8)12/h3-4H2,1-2H3,(H2,9,10,11,12,13)/p-1

描述信息

D002491 - Central Nervous System Agents > D002492 - Central Nervous System Depressants > D006993 - Hypnotics and Sedatives
D018377 - Neurotransmitter Agents > D018682 - GABA Agents > D018757 - GABA Modulators

同义名列表

1 个代谢物同义名

Medinal



数据库引用编号

2 个数据库交叉引用编号

分类词条

相关代谢途径

Reactome(0)

BioCyc(0)

PlantCyc(0)

代谢反应

0 个相关的代谢反应过程信息。

Reactome(0)

BioCyc(0)

WikiPathways(0)

Plant Reactome(0)

INOH(0)

PlantCyc(0)

COVID-19 Disease Map(0)

PathBank(0)

PharmGKB(0)

0 个相关的物种来源信息

在这里通过桑基图来展示出与当前的这个代谢物在我们的BioDeep知识库中具有相关联信息的其他代谢物。在这里进行关联的信息来源主要有:

  • PubMed: 来源于PubMed文献库中的文献信息,我们通过自然语言数据挖掘得到的在同一篇文献中被同时提及的相关代谢物列表,这个列表按照代谢物同时出现的文献数量降序排序,取前10个代谢物作为相关研究中关联性很高的代谢物集合展示在桑基图中。
  • NCBI Taxonomy: 通过文献数据挖掘,得到的代谢物物种来源信息关联。这个关联信息同样按照出现的次数降序排序,取前10个代谢物作为高关联度的代谢物集合展示在桑吉图上。
  • Chemical Taxonomy: 在物质分类上处于同一个分类集合中的其他代谢物
  • Chemical Reaction: 在化学反应过程中,存在为当前代谢物相关联的生化反应过程中的反应底物或者反应产物的关联代谢物信息。

点击图上的相关代谢物的名称,可以跳转到相关代谢物的信息页面。

亚细胞结构定位 关联基因列表


文献列表

  • Sayantan Maitra, Arnab De, Bhaskar Das, Sudipendra Nath Roy, Ranadhir Chakraborty, Amalesh Samanta, Subhrajit Bhattacharya. Seasonal Variation of Phyto-Constituents of Tea Leaves Affects Antiproliferative Potential. Journal of the American College of Nutrition. 2019 07; 38(5):415-423. doi: 10.1080/07315724.2018.1538829. [PMID: 30696389]
  • Qing Chang, Hongying Ma, Fangjie Wang, Honglian Ou, Ming Zou. [Determination of 10 sedative-hypnotics in human plasma using pulse splitless injection technique and gas chromatography-mass spectrometry]. Se pu = Chinese journal of chromatography. 2011 Nov; 29(11):1082-6. doi: . [PMID: 22393695]
  • Jin Sheng, Jianping Lei, Huangxian Ju, Chaojin Song, Daming Zhang. Rapid ultraviolet monitoring of multiple psychotropic drugs with a renewable microfluidic device. Analytica chimica acta. 2010 Oct; 679(1-2):1-6. doi: 10.1016/j.aca.2010.08.019. [PMID: 20951851]
  • Peter G Mantle, Miloslav Dobrota, Cheryl E Gillett, Edward W Odell, Sarah E Pinder. Oncological outcomes in rats given nephrocarcinogenic exposure to dietary ochratoxin a, followed by the tumour promoter sodium barbital for life: a pilot study. Toxins. 2010 04; 2(4):552-71. doi: 10.3390/toxins2040552. [PMID: 22069599]
  • Xiuyao Zhang, Xinxin Cai, Xiaoyi Zhang. [Rapid simultaneous determination of 42 psychoactive drugs and their metabolites in human plasma and urine by ultra performance liquid chromatography-tandem mass spectrometry]. Se pu = Chinese journal of chromatography. 2010 Jan; 28(1):23-33. doi: 10.3724/sp.j.1123.2010.00023. [PMID: 20458916]
  • Shuang Wang, Yuzhi Wei, Guangyu Chen, Xiaowei Liu, Haiming Jin, Zhaoqi Yan, Qiaowen Wu, Hongwu Du. Generation and utilization of anti-drug monoclonal antibodies for screening of 36 drug users by dot-ELISA. Hybridoma (2005). 2009 Apr; 28(2):145-8. doi: 10.1089/hyb.2008.0078. [PMID: 19382846]
  • Juan Lin, Wei Zhao, Fei Ding, Zhi-Qiang Jiang. [Thermochemical studies on the reaction of barbital sodium with bovine serum albumin]. Guang pu xue yu guang pu fen xi = Guang pu. 2008 Mar; 28(3):648-51. doi: NULL. [PMID: 18536434]
  • Roberto Davicino, Carolina Martinez, M Aída Mattar, Yolanda Casali, Silvia G Correa, Leslie Aragon, Elbio Antonio Saidman, German Messina, Blas Micalizzi. Larrea divaricata Cav (Jarilla): production of superoxide anion, hydrogen peroxide and expression of zymosan receptors. Immunopharmacology and immunotoxicology. 2008; 30(3):489-501. doi: 10.1080/08923970802135211. [PMID: 18668394]
  • Jimena V Lavandera, Alcira Maria Del Carmen Batlle, Ana María Buzaleh. Metabolization of porphyrinogenic agents in brain: involvement of the phase I drug metabolizing system. A comparative study in liver and kidney. Cellular and molecular neurobiology. 2007 Sep; 27(6):717-29. doi: 10.1007/s10571-007-9154-0. [PMID: 17676386]
  • NULL. [Recommended procedures for the measurement of plasma fibrinogen]. Rinsho byori. The Japanese journal of clinical pathology. 2001 Dec; 49(12):1273-9. doi: NULL. [PMID: 11797397]
  • D C Wolf, T L Goldsworthy, D B Janszen, R Harden, E M Donner, C S David, J I Everitt. Promotion by sodium barbital induces early development but does not increase the multiplicity of hereditary renal tumors in Eker rats. Carcinogenesis. 2000 Aug; 21(8):1553-8. doi: 10.1093/carcin/21.8.1553. [PMID: 10910958]
  • N Chidambaram, D J Burgess. Effect of nonionic surfactant on transport of surface-active and non-surface-active model drugs and emulsion stability in triphasic systems. AAPS pharmSci. 2000; 2(3):E30. doi: 10.1208/ps020330. [PMID: 11741246]
  • N Chidambaram, D J Burgess. Mathematical modeling of surface-active and non-surface-active drug transport in emulsion systems. AAPS pharmSci. 2000; 2(3):E31. doi: 10.1208/ps020331. [PMID: 11741247]
  • Y Martín-Biosca, S Sagrado, R M Villaneuva-Camañas, M J Medina-Hernández. Determination of barbiturates in urine by micellar liquid chromatography and direct injection of sample. Journal of pharmaceutical and biomedical analysis. 1999 Nov; 21(2):331-8. doi: 10.1016/s0731-7085(99)00147-8. [PMID: 10703988]
  • D Brochet, R Chermat, F V DeFeudis, K Drieu. Effects of single intraperitoneal injections of an extract of Ginkgo biloba (EGb 761) and its terpene trilactone constituents on barbital-induced narcosis in the mouse. General pharmacology. 1999 Sep; 33(3):249-56. doi: 10.1016/s0306-3623(99)00018-x. [PMID: 10480658]
  • M Deiwick, B Glasmacher, H A Baba, N Roeder, H Reul, G von Bally, H H Scheld. In vitro testing of bioprostheses: influence of mechanical stresses and lipids on calcification. The Annals of thoracic surgery. 1998 Dec; 66(6 Suppl):S206-11. doi: 10.1016/s0003-4975(98)01125-4. [PMID: 9930449]
  • M P Waalkes, B A Diwan, J M Ward, D E Devor, R A Goyer. Renal tubular tumors and atypical hyperplasias in B6C3F1 mice exposed to lead acetate during gestation and lactation occur with minimal chronic nephropathy. Cancer research. 1995 Nov; 55(22):5265-71. doi: NULL. [PMID: 7585586]
  • B A Diwan, L M Anderson, J M Ward, J R Henneman, J M Rice. Transplacental carcinogenesis by cisplatin in F344/NCr rats: promotion of kidney tumors by postnatal administration of sodium barbital. Toxicology and applied pharmacology. 1995 May; 132(1):115-21. doi: 10.1006/taap.1995.1092. [PMID: 7747274]
  • M Paolini, R Mesirca, L Pozzetti, A Sapone, G Cantelli-Forti. Induction of CYP2B1 mediated pentoxyresorufin O-dealkylase activity in different species, sex and tissue by prototype 2B1-inducers. Chemico-biological interactions. 1995 Mar; 95(1-2):127-39. doi: 10.1016/0009-2797(94)03352-8. [PMID: 7697745]
  • I Mahmood, D H Waters. A comparative study of uranyl nitrate and cisplatin-induced renal failure in rat. European journal of drug metabolism and pharmacokinetics. 1994 Oct; 19(4):327-36. doi: 10.1007/bf03188859. [PMID: 7737234]
  • R W Nims, R M McClain, P S Manchand, P S Belica, P E Thomas, D W Mellini, W E Utermahlen, R A Lubet. Comparative pharmacodynamics of hepatic cytochrome P450 2B induction by 5,5-diphenyl- and 5,5-diethyl-substituted barbiturates and hydantoins in the male F344/NCr rat. The Journal of pharmacology and experimental therapeutics. 1994 Jul; 270(1):348-55. doi: . [PMID: 8035330]
  • Y Kurata, B A Diwan, L Lehman-McKeeman, J M Rice, J M Ward. Comparative hyaline droplet nephropathy in male F344/NCr rats induced by sodium barbital and diethylacetylurea, a breakdown product of sodium barbital. Toxicology and applied pharmacology. 1994 Jun; 126(2):224-32. doi: 10.1006/taap.1994.1111. [PMID: 7516096]
  • C A Oborne, G Buckton, N Barber. The interaction of albumin and drugs with two haemofiltration membranes. Journal of clinical pharmacy and therapeutics. 1994 Apr; 19(2):119-25. doi: 10.1111/j.1365-2710.1994.tb01123.x. [PMID: 8071392]
  • B G Short. Cell proliferation and renal carcinogenesis. Environmental health perspectives. 1993 Dec; 101 Suppl 5(?):115-20. doi: 10.1289/ehp.93101s5115. [PMID: 7516872]
  • T Suzuki, H Mizoguchi, H Noguchi, T Yoshii, M Misawa. Effects of flunarizine and diltiazem on physical dependence on barbital in rats. Pharmacology, biochemistry, and behavior. 1993 Jul; 45(3):703-12. doi: 10.1016/0091-3057(93)90528-2. [PMID: 8392734]
  • Y Kurata, B A Diwan, H Uno, J M Rice, J M Ward. Pathology of preneoplastic and neoplastic renal tubular lesions induced in F-344 rats by sodium barbital, a nongenotoxic renal carcinogen and nephrotoxin. Toxicologic pathology. 1993; 21(1):35-45. doi: 10.1177/019262339302100105. [PMID: 8378705]
  • C M de Fiebre, R J Marley, L L Miner, N E de Fiebre, J M Wehner, A C Collins. Classical genetic analyses of responses to sedative-hypnotic drugs in crosses derived from long-sleep and short-sleep mice. Alcoholism, clinical and experimental research. 1992 Jun; 16(3):511-21. doi: 10.1111/j.1530-0277.1992.tb01409.x. [PMID: 1352660]
  • E R Korpi, K Tuominen, P T Männistö. Hormone responses to sedative drugs and cold exposure in two rat lines with high and low alcohol sensitivity. Pharmacology, biochemistry, and behavior. 1992 Apr; 41(4):795-9. doi: 10.1016/0091-3057(92)90229-9. [PMID: 1594648]
  • H Zha, G Ding, S Fan. Serum factor(s) induced by restraint stress in mice and rats suppresses lymphocyte proliferation. Brain, behavior, and immunity. 1992 Mar; 6(1):18-31. doi: 10.1016/0889-1591(92)90056-t. [PMID: 1315179]
  • Y Kurata, B A Diwan, J M Ward. Lack of renal tumour-initiating activity of a single dose of potassium bromate, a genotoxic renal carcinogen in male F344/NCr rats. Food and chemical toxicology : an international journal published for the British Industrial Biological Research Association. 1992 Mar; 30(3):251-9. doi: 10.1016/0278-6915(92)90041-i. [PMID: 1618449]
  • M Miyazaki, L Bai, S Tsuboi, M Namba. Effects of barbiturates with or without liver-tumor-promoting activity on survival and DNA synthesis of suckling and adult rat hepatocytes in serum-free primary culture. Journal of cancer research and clinical oncology. 1992; 118(6):435-40. doi: 10.1007/bf01629426. [PMID: 1618890]
  • L D Rodichok. A case of barbiturate poisoning with a readily-accessible laboratory reagent. Journal of toxicology. Clinical toxicology. 1992; 30(3):455-8. doi: 10.3109/15563659209021559. [PMID: 1512817]
  • J M Khanna, H Kalant, G Shah, A Chau. Tolerance to ethanol and cross-tolerance to pentobarbital and barbital in four rat strains. Pharmacology, biochemistry, and behavior. 1991 Jul; 39(3):705-9. doi: 10.1016/0091-3057(91)90151-q. [PMID: 1784599]
  • A Shimada, T Yanagita. Observation of the development of tolerance to and physical dependence on barbital by cortical evoked potential in rats. Japanese journal of pharmacology. 1991 May; 56(1):71-7. doi: 10.1254/jjp.56.71. [PMID: 1880988]
  • M Waked, C Bismuth, F Capron, P Taboulet. [Lipid pneumonia discovered in a case of epiphenomenal drug poisoning]. Presse medicale (Paris, France : 1983). 1991 Feb; 20(4):178. doi: ". [PMID: 1825878]
  • W H Soine, P J Soine, T M England. Barbital N-glucoside is not detected as a urinary excretion product of barbital in humans. Journal of pharmaceutical and biomedical analysis. 1991; 9(9):747-52. doi: 10.1016/0731-7085(91)80216-v. [PMID: 1821152]
  • M D Hatch. Carbonic anhydrase assay: strong inhibition of the leaf enzyme by CO2 in certain buffers. Analytical biochemistry. 1991 Jan; 192(1):85-9. doi: 10.1016/0003-2697(91)90189-z. [PMID: 1904692]
  • N Konishi, B A Diwan, J M Ward. Amelioration of sodium barbital-induced nephropathy and regenerative tubular hyperplasia after a single injection of streptozotocin does not abolish the renal tumor promoting effect of barbital sodium in male F344/NC4 rats. Carcinogenesis. 1990 Dec; 11(12):2149-56. doi: 10.1093/carcin/11.12.2149. [PMID: 2148284]
  • A Zgirski, E Frieden. Binding of Cu(II) to non-prosthetic sites in ceruloplasmin and bovine serum albumin. Journal of inorganic biochemistry. 1990 Jun; 39(2):137-48. doi: 10.1016/0162-0134(90)80022-p. [PMID: 2380706]
  • N Konishi, P J Donovan, J M Ward. Differential effects of renal carcinogens and tumor promoters on growth promotion and inhibition of gap junctional communication in two rat renal epithelial cell lines. Carcinogenesis. 1990 Jun; 11(6):903-8. doi: 10.1093/carcin/11.6.903. [PMID: 2140731]
  • S K Jain. Hyperglycemia can cause membrane lipid peroxidation and osmotic fragility in human red blood cells. The Journal of biological chemistry. 1989 Dec; 264(35):21340-5. doi: . [PMID: 2592379]
  • A Hagiwara, B A Diwan, J M Ward. Barbital sodium, a tumor promoter for kidney tubules, urinary bladder, and liver of the F344 rat, induces persistent increases in levels of DNA synthesis in renal tubules but not in urinary bladder epithelium or hepatocytes. Fundamental and applied toxicology : official journal of the Society of Toxicology. 1989 Aug; 13(2):332-40. doi: 10.1016/0272-0590(89)90269-8. [PMID: 2792600]
  • B A Diwan, R W Nims, J M Ward, H Hu, R A Lubet, J M Rice. Tumor promoting activities of ethylphenylacetylurea and diethylacetylurea, the ring hydrolysis products of barbiturate tumor promoters phenobarbital and barbital, in rat liver and kidney initiated by N-nitrosodiethylamine. Carcinogenesis. 1989 Jan; 10(1):189-94. doi: 10.1093/carcin/10.1.189. [PMID: 2910522]
  • B A Diwan, M Ohshima, J M Rice. Promotion by sodium barbital of renal cortical and transitional cell tumors, but not intestinal tumors, in F344 rats given methyl(acetoxymethyl)nitrosamine, and lack of effect of phenobarbital, amobarbital, or barbituric acid on development of either renal or intestinal tumors. Carcinogenesis. 1989 Jan; 10(1):183-8. doi: 10.1093/carcin/10.1.183. [PMID: 2910521]
  • J M Ward, A Hagiwara, L M Anderson, K Lindsey, B A Diwan. The chronic hepatic or renal toxicity of di(2-ethylhexyl) phthalate, acetaminophen, sodium barbital, and phenobarbital in male B6C3F1 mice: autoradiographic, immunohistochemical, and biochemical evidence for levels of DNA synthesis not associated with carcinogenesis or tumor promotion. Toxicology and applied pharmacology. 1988 Dec; 96(3):494-506. doi: 10.1016/0041-008x(88)90009-9. [PMID: 3206528]
  • M M Farag, L Volicer. Acute hepatic damage in rats impairs metharbital metabolism. Pharmacology. 1987; 34(4):181-91. doi: 10.1159/000138268. [PMID: 2885858]
  • K Hellevuo, K Kiianmaa, A Juhakoski, C Kim. Intoxicating effects of lorazepam and barbital in rat lines selected for differential sensitivity to ethanol. Psychopharmacology. 1987; 91(3):263-7. doi: 10.1007/bf00518174. [PMID: 3104948]
  • S T O'Rourke, J D Folts, R M Albrecht. Inhibition of canine platelet aggregation by barbiturates. The Journal of laboratory and clinical medicine. 1986 Sep; 108(3):206-12. doi: . [PMID: 3091745]
  • T Richardson, M C Robinson, D Dawson, M Pye. A case of barbital poisoning. Clinical chemistry. 1985 Oct; 31(10):1770-1. doi: NULL. [PMID: 4042346]
  • S J Lane, W W Morgan. Development of tolerance to chronic barbital treatment in the cerebellar cyclic guanosine monophosphate system and its response to subsequent barbital abstinence. The Journal of pharmacology and experimental therapeutics. 1985 Sep; 234(3):569-74. doi: NULL. [PMID: 2993585]
  • P L Gray, P V Taberner. Evidence for GABA tolerance in barbiturate-dependent and withdrawn mice. Neuropharmacology. 1985 May; 24(5):437-44. doi: 10.1016/0028-3908(85)90029-2. [PMID: 2991801]
  • K M Pathak, S N Gaur, S K Garg. Counter current immunoelectrophoresis, a new technique for the rapid serodiagnosis of porcine cysticercosis. Journal of helminthology. 1984 Dec; 58(4):321-4. doi: 10.1017/s0022149x00025190. [PMID: 6520375]
  • S J Lane, W W Morgan. The effects of chronic oral administration of barbital on cerebellar cyclic GMP. Neuropharmacology. 1984 Jul; 23(7A):779-83. doi: 10.1016/0028-3908(84)90111-4. [PMID: 6089024]
  • D D Koblin, F W Lurz, B O'Connor, N T Nelson, E I Eger, C R Bainton. Potencies of barbiturates in mice selectively bred for resistance or susceptibility to nitrous oxide anesthesia. Anesthesia and analgesia. 1984 Jan; 63(1):35-9. doi: . [PMID: 6691562]
  • T Agishi, K Yamagata, M Kobayashi, S Teraoka, H Honda, K Ota. Normothermic whole body rinse-out utilizing perfluorochemical(PFC)-containing artificial blood. Transactions - American Society for Artificial Internal Organs. 1984; 30(?):295-7. doi: NULL. [PMID: 6533899]
  • A C McRae, T G Kennedy. Selective permeability of the blood-uterine lumen barrier in rats: importance of lipid solubility. Biology of reproduction. 1983 Nov; 29(4):886-94. doi: 10.1095/biolreprod29.4.886. [PMID: 6416321]
  • J Sato, M Nioka, E Owada, K Ito, T Murata. Effect of acetazolamide on the anticonvulsant potency of several antiepileptic drugs in mice. Journal of pharmacobio-dynamics. 1983 May; 6(5):295-300. doi: 10.1248/bpb1978.6.295. [PMID: 6137528]
  • B N Matiushin, A S Loginov, L Kh Ausheva, E A Bendikov, T V Nilova. [Activity of microsomal enzymes and lipid peroxidation in the liver in galactosamine injury]. Biulleten' eksperimental'noi biologii i meditsiny. 1983 Feb; 95(2):53-5. doi: ". [PMID: 6824777]
  • C D Lox, N Frederick. Clotting activity in the rat following acute barbiturate treatment. General pharmacology. 1983; 14(5):529-31. doi: 10.1016/0306-3623(83)90114-3. [PMID: 6642193]
  • M A Graham, A Poklis, M A Mackell, G E Gantner. A case of suicide involving the concomitant intravenous injection of barbital and oral ingestion of arsenic. Journal of forensic sciences. 1983 Jan; 28(1):251-4. doi: NULL. [PMID: 6680743]
  • P De Nayer, P Malvaux. Hyperthyroxinemia associated with high thyroxine binding to albumin in euthyroid subjects. Journal of endocrinological investigation. 1982 Nov; 5(6):383-6. doi: 10.1007/bf03350537. [PMID: 6820373]
  • J W Barlow, J M Csicsmann, E L White, J W Funder, J R Stockigt. Familial euthyroid thyroxine excess: characterization of abnormal intermediate affinity thyroxine binding to albumin. The Journal of clinical endocrinology and metabolism. 1982 Aug; 55(2):244-50. doi: 10.1210/jcem-55-2-244. [PMID: 6806311]
  • Y Hiasa, Y Kitahori, M Ohshima, T Fujita, T Yuasa, N Konishi, A Miyashiro. Promoting effects of phenobarbital and barbital on development of thyroid tumors in rats treated with N-bis(2-hydroxypropyl)nitrosamine. Carcinogenesis. 1982; 3(10):1187-90. doi: 10.1093/carcin/3.10.1187. [PMID: 7172417]
  • M Ching. Effect of barbital on the pituitary-thyroid axis. Journal of endocrinological investigation. 1981 Oct; 4(4):389-92. doi: 10.1007/bf03348300. [PMID: 7334184]
  • J R Stockigt, D J Topliss, J W Barlow, E L White, D M Hurley, P Taft. Familial euthyroid thyroxine excess: an appropriate response to abnormal thyroxine binding associated with albumin. The Journal of clinical endocrinology and metabolism. 1981 Aug; 53(2):353-9. doi: 10.1210/jcem-53-2-353. [PMID: 6166631]
  • F F Morpeth, F M Dickinson. Kinetic studies of the mechanism of pig kidney aldehyde reductase. The Biochemical journal. 1981 Feb; 193(2):485-92. doi: 10.1042/bj1930485. [PMID: 7030310]
  • K Matsuyama, K Kado, M Nishiuchi, T Goromaru, O Tsuzuki, A Noda, S Iguchi. Characteristic biotransformation of aminopyrine in rat when administered with barbital. Journal of pharmacobio-dynamics. 1981 Jan; 4(1):28-34. doi: 10.1248/bpb1978.4.28. [PMID: 7277190]
  • S Tamura, Y Matsumoto. Comparative studies on postnatal development of liver beta-glucuronidase activity between Gunn rats and Wistar rats. The Journal of toxicological sciences. 1980 Nov; 5(4):331-8. doi: 10.2131/jts.5.331. [PMID: 7218379]
  • B A Flint, I K Ho. Continuous administration of barbital by pellet implantation. Journal of pharmacological methods. 1980 Sep; 4(2):127-39. doi: 10.1016/0160-5402(80)90032-7. [PMID: 7192783]
  • F Varin, C Marchand, P Larochelle, K K Midha. GLC-mass spectrometric procedure with selected-ion monitoring for determination of plasma concentrations of unlabeled and labeled barbital following simultaneous oral and intravenous administration. Journal of pharmaceutical sciences. 1980 Jun; 69(6):640-3. doi: 10.1002/jps.2600690608. [PMID: 7205573]
  • P J Davis, K Yoshida, M Schoenl. Interaction of thyroid hormone and hemoglobin. I. Nature of the interaction and effect of hemoglobin on thyroid hormone radioimmunoassay. The Journal of laboratory and clinical medicine. 1980 May; 95(5):714-24. doi: NULL. [PMID: 7365316]
  • K J Gundermann, T S Lie. Problems of competition in charcoal hemoperfusion for the treatment of intoxications. Artificial organs. 1979 Nov; 3(4):346-9. doi: 10.1111/j.1525-1594.1979.tb01075.x. [PMID: 533425]
  • M Tang, C E Lau, J L Falk. Serum phenobarbital and barbital concentrations in rats on a limited food regimen. Pharmacology, biochemistry, and behavior. 1979 Sep; 11(3):359-61. doi: 10.1016/0091-3057(79)90150-3. [PMID: 504317]
  • H A Kordan, P M Mumford. Effects of oxybarbiturates on the germination behaviour of Impatiens bolstii pollen. European journal of cell biology. 1979 Aug; 19(3):299-302. doi: ". [PMID: 488129]
  • M Sharkawi. Influence of the dopamine-beta-hydroxylase inhibitor FLA 63 on the disposition of barbitone in the mouse. The Journal of pharmacy and pharmacology. 1979 May; 31(5):340-1. doi: 10.1111/j.2042-7158.1979.tb13515.x. [PMID: 37309]
  • P Kramp, P Rønsted, T Hansen. Barbital and diazepam plasma levels during treatment of delirium tremens. Acta psychiatrica Scandinavica. 1979 Mar; 59(3):263-75. doi: 10.1111/j.1600-0447.1979.tb06966.x. [PMID: 373390]
  • J M Carney, J A Rosecrans, M R Vasko. Barbitone-induced tolerance to the effects of sedative-hypnotics and related compounds on operant behaviour in the rat. British journal of pharmacology. 1979 Feb; 65(2):183-92. doi: 10.1111/j.1476-5381.1979.tb07817.x. [PMID: 760896]
  • G Hampel, B Widdop, R Goulding. Adsorptive capacities of hemoperfusion devices in clinical use. Artificial organs. 1978 Nov; 2(4):363-6. doi: 10.1111/j.1525-1594.1978.tb01622.x. [PMID: 743006]
  • G Wahlström. Increased penetration of barbital through the bloodbrain barrier in the rat after pretreatment with probenecid. Acta pharmacologica et toxicologica. 1978 Oct; 43(4):260-5. doi: 10.1111/j.1600-0773.1978.tb02263.x. [PMID: 716942]
  • M Sharkawi, D Cianflone. Disulfiram enhances pharmacological activity of barbital and impairs its urinary elimination. Science (New York, N.Y.). 1978 Aug; 201(4355):543-4. doi: 10.1126/science.663674. [PMID: 663674]
  • V I Popova. [Isolation of barbamyl and barbital from biological material by a gel chromatographic method]. Sudebno-meditsinskaia ekspertiza. 1978 Jul; 21(3):40-2. doi: NULL. [PMID: 675761]
  • A Tatematsu, H Yoshizumi, T Nadai, T Kubodera, S Asai. Mass spectrometry of medicines. Quantitative determination by direct probe inlet system mass chromatography. Biomedical mass spectrometry. 1978 Mar; 5(3):192-7. doi: 10.1002/bms.1200050306. [PMID: 24482]
  • H R Stephens, D Nadeau, E B Sandborn. Absorption and distribution of sodium [2-14C]barbital in tissues of normal and dystrophic mice. Canadian journal of physiology and pharmacology. 1978 Feb; 56(1):76-82. doi: 10.1139/y78-011. [PMID: 638861]
  • B Crane, C Lane. Modified semiautomated method for free fatty acids in serum. Journal of clinical pathology. 1977 Aug; 30(8):754-7. doi: 10.1136/jcp.30.8.754. [PMID: 599188]
  • S Takeuchi, A Maeda. Use of fluorescein mercuric acetate as a probe in studies of thiol-containing proteins. Journal of biochemistry. 1977 Apr; 81(4):971-6. doi: 10.1093/oxfordjournals.jbchem.a131563. [PMID: 881421]
  • A S Pang, W P Aston. Alternative complement pathway in bovine serum: lysis of human erythrocytes. American journal of veterinary research. 1977 Mar; 38(3):355-9. doi: NULL. [PMID: 403835]
  • M M Meshali, C H Nightingale. The effect of alpha-tocopherol deficiency on the pharmacokinetics and pharmacological effect of barbital. Life sciences. 1976 Jul; 19(2):163-74. doi: 10.1016/0024-3205(76)90387-8. [PMID: 957863]
  • A Zune, P Dobberstein, K H Maurer, U Rapp. Identification of drugs using a gas chromatography-mass spectrometry system equipped with electron impact-chemical ionization and electron impact-field ionizationfield desorption combination sources. Journal of chromatography. 1976 Jul; 122(?):365-71. doi: 10.1016/s0021-9673(00)82259-1. [PMID: 932159]
  • S O Byers, M Friedman. Phenobarbital as a hypocholesterolemic agent in the rat and rabbit. Metabolism: clinical and experimental. 1976 Jul; 25(7):727-37. doi: 10.1016/0026-0495(76)90144-x. [PMID: 940469]
  • L Nye, M Hassan, E Willmott, J Landon. Introduction of a rapid, simple radioimmunoassay and quality control scheme for thyroxine. Journal of clinical pathology. 1976 May; 29(5):452-7. doi: 10.1136/jcp.29.5.452. [PMID: 932232]
  • M M Meshali, C H Nightingale. Effect of alpha tocopherol (vitamin E) deficiency on intestinal transport of passively absorbed drugs. Journal of pharmaceutical sciences. 1976 Mar; 65(3):344-8. doi: 10.1002/jps.2600650307. [PMID: 1263079]
  • J P Anhalt, P K Yu. Counterimmunoelectrophoresis of pneumococcal antigens:improved sensitivity for the detection of types VII and XIV. Journal of clinical microbiology. 1975 Dec; 2(6):510-5. doi: 10.1128/jcm.2.6.510-515.1975. [PMID: 1417]
  • H Losse. Treatment of renal hypertension. Clinical nephrology. 1975 Nov; 4(5):194-7. doi: . [PMID: 167]
  • D N Bailey, P I Jatlow. Barbital overdose and abuse. American journal of clinical pathology. 1975 Sep; 64(3):291-6. doi: 10.1093/ajcp/64.3.291. [PMID: 1163482]
  • N Waters, T J Gaha, I Reynolds. Random urine analyses from drug addicts in a methadone treatment programme. The Medical journal of Australia. 1975 Aug; 2(5):170-2. doi: 10.5694/j.1326-5377.1975.tb99494.x. [PMID: 1160755]
  • M Pracharová, M Pestálovă, H Dubský, K Hána. [Determination of barbiturates from biological material]. Soudni lekarstvi. 1975 Aug; 20(3):38-42. doi: NULL. [PMID: 1860]
  • S K Lee, J Singh, R B Taylor. Subclasses of T cells with different sensitivities to cytotoxic antibody in the presence of anesthetics. European journal of immunology. 1975 Apr; 5(4):259-62. doi: 10.1002/eji.1830050408. [PMID: 1086230]
  • J G Barth. [Determination of the activity of serum ornithine carbamoyltranferase : working conditions in a veronal-acetate medium]. Annales de biologie clinique. 1975; 33(4):309-17. doi: . [PMID: 2089]
  • A G EBERT, G K YIM, T S MIYA. DISTRIBUTION AND METABOLISM OF BARBITAL-14C IN TOLERANT AND NONTOLERANT RATS. Biochemical pharmacology. 1964 Sep; 13(?):1267-74. doi: 10.1016/0006-2952(64)90227-8. [PMID: 14221724]